Healthy volunteers needed to test drug absorption
NCT ID NCT07236411
First seen Nov 19, 2025 · Last updated May 15, 2026 · Updated 30 times
Summary
This study looks at how a new drug called cizutamig enters the bloodstream when given as a shot or under the skin. It involves 24 healthy adults aged 18 to 65. The goal is to measure the drug's bioavailability, not to treat any disease.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY PARTICIPANTS STUDY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Nucleus Network
Melbourne, Victoria, 3004, Australia
Conditions
Explore the condition pages connected to this study.